Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate in Sudden Sensorineural Hearing Loss
NCT05403229Phase 2Recruiting
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Oct 2022
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topiramate in sudden sensorineural hearing loss (SSHL), sponsored by Chang Gung Memorial Hospital. Started Oct 2022; status: recruiting.
02
Drugs
topiramate
03
Conditions
sudden sensorineural hearing loss (SSHL)
Beyond the preview
Go deeper on NCT05403229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05403229.